Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2025)

Historic Gross Profit for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $160.6 million.

  • Kiniksa Pharmaceuticals International's Gross Profit rose 7436.4% to $160.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $523.3 million, marking a year-over-year increase of 5787.3%. This contributed to the annual value of $362.3 million for FY2024, which is 5297.7% up from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Gross Profit is $160.6 million, which was up 7436.4% from $138.2 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Gross Profit high stood at $160.6 million for Q3 2025, and its period low was -$155.0 million during Q4 2022.
  • For the 5-year period, Kiniksa Pharmaceuticals International's Gross Profit averaged around $57.8 million, with its median value being $66.5 million (2023).
  • Within the past 5 years, the most significant YoY rise in Kiniksa Pharmaceuticals International's Gross Profit was 88840.05% (2022), while the steepest drop was 114184.7% (2022).
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Gross Profit stood at $14.9 million in 2021, then tumbled by 1141.85% to -$155.0 million in 2022, then surged by 147.62% to $73.8 million in 2023, then soared by 41.77% to $104.6 million in 2024, then skyrocketed by 53.48% to $160.6 million in 2025.
  • Its Gross Profit stands at $160.6 million for Q3 2025, versus $138.2 million for Q2 2025 and $119.9 million for Q1 2025.